Strides Pharma names Nandini Matiyani Global Head of HR

Strides Pharma Science has appointed Nandini Matiyani as Executive Vice President and Global Head of Human Resources, strengthening the company’s leadership bench as it scales its global operations.

In a post on LinkedIn, Matiyani said she was “embarking on a new journey” with Strides and will lead the global HR function across the pharmaceutical group’s international footprint. She thanked Chairman Arun Kumar, Managing Director and Group CEO Badri Srinivasan, and the board for their confidence in her appointment.

Matiyani brings more than 20 years of experience in people strategy, cultural transformation and HR leadership across multinational and publicly listed organisations. She said her focus at Strides will be on strengthening capabilities, reinforcing culture and supporting the company’s ambition to deliver “better and fairer healthcare” through agility, innovation and meaningful people practices.

Strides, established in 1990 and headquartered in Bengaluru, operates in more than 100 countries, supplying regulated markets, donor-funded channels and its “in Africa for Africa” business. The company manufactures complex pharmaceutical products from sites in India, Italy, Kenya and the United States.

Matiyani said she looks forward to working with teams across geographies to build talent strength and organisational capacity as Strides accelerates its global agenda. Her appointment underscores the company’s focus on leadership development and culture building as it competes in highly regulated and cost-sensitive markets.

The company has not announced further organisational changes, but the expanded HR leadership role signals a sharper emphasis on people systems and capability building as Strides targets growth across key markets.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg